In Association With Novotech

Accelerating Clinical Trials

Partner Content

Small cell lung cancer: Navigating the global clinical trial landscape

Discover the latest advancements in small cell lung cancer through Novotech CRO’s in-depth disease analysis. Gain valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping the treatment of small cell lung cancer.

Partner Content

Cervical cancer: Navigating today’s global clinical trial landscape

Partner Content

Pancreatic cancer: The clinical trial landscape and progress for 2024

Partner Content

Oesophageal cancer: the global clinical trials landscape in 2024

Partner Content

Chronic Lymphocytic Leukaemia: the global clinical trials landscape in 2024

Partner Content

Non-small cell lung cancer: the global clinical trials landscape 2024

Partner Content

Navigating the global epilepsy clinical trial landscape in 2024

Partner Content

Cystic fibrosis: global clinical trials landscape and treatments

Partner Content

Duchenne Muscular Dystrophy: the global clinical trials landscape 2024

Partner Content

Rheumatoid arthritis in 2024: Navigating the global clinical trial landscape

Partner Content

Candidiasis: global clinical trials and emerging treatments

Partner Content

Expert analysis: the latest in HIV research and clinical trials

Partner Content

From regulations to rare diseases: Navigating the FDA review process

Partner Content

Trends in global vaccine development: 2023 and beyond

Partner Content

Asia Pacific dominates Phase I clinical trials: a trend analysis

Partner Content

Growth opportunities: The clinical trials landscape of Asia-Pacific

Partner Content

The top five global biotech trends of the last five years

Partner Content

New territories: Challenges and benefits for western biotechs in China

Partner Content

Clinical development activity in APAC region surges, boosted by CAR-T clinical development in China

Partner Content

A preferred destination: what’s driving Asia Pacific’s growth as a clinical trial hotspot

Partner Content

The next generation of DCTs: inside the technology transforming clinical trials

Partner Content

A booming market: Why the Chinese biotech sector is primed for growth

Partner Content

Clinical trial trends in 2022: Prepare for an agile future

Partner Content

Why Asia-Pacific is the next frontier for decentralised clinical trials

Partner Content

Four key strategies for Western biotechs to expedite drug development in China

Partner Content

Home to around 20% of the world’s population, research regulatory reform creates tremendous opportunity for Western biotechs in China

Accelerating Clinical Trials

How a drug development plan can save your biotech money

Accelerating Clinical Trials

The benefit of running clinical trials in Asia-Pacific for biotech companies

Accelerating Clinical Trials

Is Australia the future for successful first-in-human clinical studies?

Partner Content

How biotechs can tap APAC for excellence in oncology trials

Partner Content

Why Asia-Pacific attracts 60% of all ongoing and planned hepatology trials globally

Partner Content

Clinical Trial Continuity in Asia-Pacific during the COVID-19 pandemic

Partner Content

Biotechs testing for COVID-19 in Asia-Pacific benefit from new fast-track review processes

Partner Content

Data shows majority of Australian sites are open for clinical trial activity

Partner Content

Managing the Covid-19 outbreak: Lessons learnt from South Korea

Annaliese Watkins

Partner Content

Clinical trials data report for Asia-Pacific: Frost & Sullivan collaborates with Novotech

Partner Content

Novotech case study: Global reach through CRO partnership for a phase 2 oncology trial

Partner Content

Case studies in accelerating clinical trials in oncology

Annaliese Watkins

Most Popular

Partner Content

Small cell lung cancer: Navigating the global clinical trial landscape

Partner Content

Cervical cancer: Navigating today’s global clinical trial landscape

Partner Content

Pancreatic cancer: The clinical trial landscape and progress for 2024

Partner Content

Oesophageal cancer: the global clinical trials landscape in 2024

White Papers

Novotech

State of the Global Biotech Landscape: Where the Opportunities Lie

Evolution of clinical trials in the Asia Pacific region compared to the US and the EU5

The China Biotech Landscape – Opportunities in China and the Path to USFDA Approval

State of the Global Biotech Landscape: Where the Opportunities Lie

Navigating the FDA Approval Processes: Capitalize on Regulatory Expertise to Simplify the Complex

HIV – Global Clinical Trial Landscape

Candidiasis – Global Clinical Trial Landscape

Rheumatoid Arthritis – Global Clinical Trial Landscape

Duchenne Muscular Dystrophy - Global Clinical Trial Landscape (2024)

Cystic Fibrosis – Global Clinical Trial Landscape (2024)

Epilepsy - Global Clinical Trial Landscape (2024)

Non-Small Cell Lung Cancer - Global Clinical Trial Landscape (2024)

Chronic Lymphocytic Leukemia: Global Clinical Trial Landscape (2024)

Oesophageal Cancer - Global Clinical Trial Landscape (2024)

Pancreatic Cancer Global Clinical Trial Landscape (2024)

Cervical Cancer – Global Clinical Trial Landscape (2024)

Small Cell Lung Cancer: Global Clinical Trial Landscape (2024)

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close